[Corrigendum] Inhibition of Rac1 reverses enzalutamide resistance in castration‑resistant prostate cancer

Read full text
Authors: Xiaoliang Chen, Lili Yin, Gan Qiao, Yanhua Li, Baoyuan Li, Yunfeng Bai, Feng Feng
Cited by: 0

Abstract

following the publication of the above article, an interested reader drew to the authors' attention that, for the Transwell migration assay experiments shown in fig.3a on p. 3001, the sh-Ctl/DMSO and sh-Ct/Enza data panels appeared to contain an overlapping section of data, such that these data panels were apparently derived from the same original source where the results of different experiments were intended to have been portrayed.The authors were able to consult their original data, and realized that this figure had inadvertently been assembled incorrectly.The revised version of fig.3, now showing the correct data for the sh-Ct/Enza panel, is shown on the next page.The authors regret that this error occurred in the original published version of this figure, although this did not grossly affect the results or the conclusions reported in this article.all the authors agree with the publication of this Corrigendum, and thank the Editor of Oncology Letters for allowing them the opportunity to publish this; furthermore, they apologize to the readership for any inconvenience caused.

Fields of Study & Subjects

Prostate Cancer Treatment and Research Lung Cancer Treatments and Mutations Cancer Lipids and Metabolism

Publication details

Journal / source
Oncology Letters
Volume
31
Issue
5
Pages
1–2
Publication date
11 March 2026
Language
EN